DEBORAH L CHUA
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NEW YORK, NY NPI 1629237607
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NY ABBVIE INC. All categories
General Payments — all program years on this page
$4,305.10
- Category: General Payments
- Program years: PY2018–2024
- Record count: 236
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $469.17 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $469.17 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $150.00 | 1 |
| Phathom Pharmaceuticals, Inc. | $141.76 | 1 |
| Celgene Corporation | $56.14 | 2 |
| Janssen Biotech, Inc. | $37.74 | 1 |
| GENZYME CORPORATION | $32.23 | 1 |
| Merck Sharp & Dohme Corporation | $28.20 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.10 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078441075 | Janssen Biotech, Inc. | $37.74 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101120513 | Celgene Corporation | $28.11 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101120517 | Celgene Corporation | $28.03 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103471317 | ABBVIE INC. | $150.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137512940 | Takeda Pharmaceuticals U.S.A., Inc. | $23.10 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139869785 | GENZYME CORPORATION | $32.23 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141904542 | Merck Sharp & Dohme LLC | $28.20 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151050051 | Phathom Pharmaceuticals, Inc. | $141.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.